Concepedia

Belinda M. Dcosta

BM

20

Publications

1.2K

Citations

17

H-Index

2020

Active since

Affiliations

New York University(Current)

Biohaven Pharmaceuticals (United States)

Belinda M. Dcosta is an author at New York University specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

2020–2023

20

Publications

20

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

Takuya Tada, Hao Zhou, Belinda M. Dcosta et al. · EBioMedicine · 2022 · 148 citations · Full text

Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies

Takuya Tada, Belinda M. Dcosta, Marie Samanovic-Golden et al. · 2021 · 114 citations · Full text

Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants

Takuya Tada, Hao Zhou, Marie I. Samanovic et al. · 2021 · 108 citations · Full text

Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies

Hao Zhou, Belinda M. Dcosta, Nathaniel R. Landau et al. · Viruses · 2022 · 93 citations · Full text

, , +12

An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2

Takuya Tada, Fan Chen, Jennifer Chen et al. · Cell Reports · 2020 · 87 citations · Full text

, , +15

Rows per page

1–5 of 20